Mirum Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Mirum Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2019 to Q2 2024.
  • Mirum Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $11.8M, a 41.6% increase year-over-year.
  • Mirum Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $41.4M, a 34.7% increase year-over-year.
  • Mirum Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $35M, a 29.7% increase from 2022.
  • Mirum Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $27M, a 17.3% increase from 2021.
  • Mirum Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $23M, a 83.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $41.4M $11.8M +$3.48M +41.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $37.9M $11.5M +$2.89M +33.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $35M $9.72M +$2.82M +40.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 $32.2M $8.39M +$1.48M +21.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $30.7M $8.36M +$1.72M +25.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $29M $8.56M +$2M +30.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $27M $6.9M +$1.4M +25.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 $25.6M $6.91M -$507K -6.84% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $26.1M $6.64M +$1.82M +37.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $24.3M $6.56M +$1.28M +24.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $23M $5.49M +$1.91M +53.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-15
Q3 2021 $21.1M $7.42M +$3.99M +116% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $17.1M $4.82M +$1.85M +62.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $15.3M $5.29M +$2.71M +105% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $12.6M $3.58M +$1.51M +73.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-09
Q3 2020 $11M $3.43M +$1.28M +59.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $9.76M $2.97M +$1.33M +81.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $8.43M $2.57M +$2.36M +1080% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $6.07M $2.07M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-09
Q3 2019 $2.14M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $1.64M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $218K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.